Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

32

Address:

Acasti Pharma Inc. 545, Promenade du Centropolis Suite 100 Laval QC H7T 0A3 Canada

Website:

http://www.acastipharma.com

Phone:

450-687-2262

Leave a comment

Your email address will not be published. Required fields are marked *